Resultados de la búsqueda 231-240 of 13369 for Malaria

1. Nutrición y comida saludable LGBTQ health - Mayo Clinic

   Puedes hacerte experto en comida saludable aprendiendo cómo planear comidas y hacer compras de manera inteligente, y practicando técnicas para preparar ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...

3. Transplant Center de Mayo Clinic - Ensayos clínicos

   Patients awaiting heart transplantation on temporary mechanical support often experience pain and anxiety, and their pre-transplant hospital course is often ...

4. Cirugía - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to do data collection of EEG findings to determine whether new types analysis of intracranial EEG can add different and ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple myeloma.

7. Hematología - Ensayos clínicos - Mayo Clinic

   This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Molecular characterization may include short tandem DNA repeat; STR) and oncogenic/tumor suppressor gene mutation analyses to assure that the derived models ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...